# v3.3

Data released on April 14, 2021

## Related releases
https://www.oncokb.org/news#04142021

## Data Changes
Gene:
RTEL1 Gene Background Updated

Alteration:
ALK D1203N, Oncogenicity Updated
	 New: Resistance
	 Old: Inconclusive
ALK E1210K, Oncogenicity Updated
ALK I1171S, Oncogenicity Updated
ALK L1152P, Oncogenicity Updated
ALK L1198P, Oncogenicity Updated
ALK C1156F, Oncogenicity Updated
ALK L1122V, Oncogenicity Updated
ALK M1328I, Oncogenicity Updated
ALK N1178H, Oncogenicity Updated
ALK P1139S, Oncogenicity Updated
ALK Q1064R, Oncogenicity Updated
ALK S1206C, Oncogenicity Updated
	 Old: Yes
ALK S1206R, Oncogenicity Updated
ALK V1180L, Oncogenicity Updated
ALK L1196Q, Oncogenicity Updated
ALK G1128S, Oncogenicity Updated
	 New: Likely Neutral
ALK T1151K, Oncogenicity Updated
CTNNB1 N387K, Oncogenicity Updated
	 New: Yes
	 Old: Likely
CTNNB1 K335I, Oncogenicity Updated
GATA3 R177Pfs*126 Deleted
NRAS A146T Added
RTEL1 M492I, Mutation Effect Description Updated
RTEL1 M492I Name Changed
	 New: M492I
	 Old: M516I
SMAD2 S465A Added
SMAD2 S467A Added
TFE3 SFPQ-TFE3 Fusion Added
Evidence:
BRAF V600E, Biliary Tract Cancer, NOS Added
EGFR 762_823ins [Exon 20 insertion], Non-Small Cell Lung Cancer, Tumor Type Summary Updated
EGFR 762_823ins [Exon 20 insertion], Non-Small Cell Lung Cancer, Amivantamab 3A Added
EGFR 762_823ins [Exon 20 insertion], Non-Small Cell Lung Cancer, Mobocertinib 3A Added
EGFR 762_823ins [Exon 20 insertion], Other Tumor Types, Tumor Type Summary Updated
FGFR1 Fusions, Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement, Tumor Type Summary Updated
FGFR1 Fusions, Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement, Pemigatinib 2 Added
FGFR1 Fusions, Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement Name Changed
	 New: Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
	 Old: Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2
HRAS Oncogenic Mutations, Bladder Urothelial Carcinoma Added
HRAS Oncogenic Mutations, Other Tumor Types, Tumor Type Summary Updated
IDH1 Oncogenic Mutations, Chondrosarcoma Added
JAK2 Fusions, Myeloid/Lymphoid Neoplasms with PCM1-JAK2 Added
KRAS G12C, Non-Small Cell Lung Cancer, Tumor Type Summary Updated
KRAS G12C, Non-Small Cell Lung Cancer, Adagrasib 3A Added
KRAS G12C, Colorectal Cancer, Tumor Type Summary Updated
KRAS G12C, Other Solid Tumor Types, Tumor Type Summary Updated
NRAS Oncogenic Mutations, Melanoma, Binimetinib 3A Deleted
NRAS Oncogenic Mutations, Melanoma, Binimetinib 3A Added
TSC2 Oncogenic Mutations, Perivascular Epithelioid Cell Tumor, Tumor Type Summary Updated
TSC2 Oncogenic Mutations, Perivascular Epithelioid Cell Tumor, ABI-009 3A Added
